PYC Therapeutics Ltd
ASX:PYC

Watchlist Manager
PYC Therapeutics Ltd Logo
PYC Therapeutics Ltd
ASX:PYC
Watchlist
Price: 1.2 AUD Market Closed
Market Cap: 699.9m AUD

Intrinsic Value

PYC's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one PYC stock under the Base Case scenario is 0.56 AUD. Compared to the current market price of 1.2 AUD, PYC Therapeutics Ltd is Overvalued by 54%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PYC Intrinsic Value
0.56 AUD
Overvaluation 54%
Intrinsic Value
Price
Base Case Scenario

Valuation History
PYC Therapeutics Ltd

Valuation History Unavailable

Historical valuation for PYC cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

PYC Therapeutics’ valuation hinges on the success of its lead candidate targeting inherited retinal diseases, and any setback in clinical trials could severely diminish investor confidence and heighten the company’s cash burn rate.

Bull Theses

PYC Therapeutics’ precision RNA platform has shown promising preclinical data that could pave the way for a breakthrough therapy in inherited retinal diseases, unlocking substantial market potential for targeted treatments.

Show More Less
How do you feel about PYC?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about PYC Therapeutics Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
PYC Therapeutics Ltd

Current Assets 62.1m
Cash & Short-Term Investments 49.3m
Receivables 12.3m
Other Current Assets 605.5k
Non-Current Assets 6.1m
PP&E 2.2m
Intangibles 4m
Efficiency

Free Cash Flow Analysis
PYC Therapeutics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
PYC Therapeutics Ltd

Revenue
26.4m AUD
Operating Expenses
-75m AUD
Operating Income
-48.5m AUD
Other Expenses
332.1k AUD
Net Income
-48.2m AUD
Fundamental Scores

PYC Profitability Score
Profitability Due Diligence

PYC Therapeutics Ltd's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
Negative Revenue Growth Forecast
Declining ROE
19/100
Profitability
Score

PYC Therapeutics Ltd's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

PYC Solvency Score
Solvency Due Diligence

PYC Therapeutics Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

PYC Therapeutics Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PYC Price Targets Summary
PYC Therapeutics Ltd

Wall Street analysts forecast PYC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PYC is 3.48 AUD with a low forecast of 2.32 AUD and a high forecast of 5.01 AUD.

Lowest
Price Target
2.32 AUD
94% Upside
Average
Price Target
3.48 AUD
190% Upside
Highest
Price Target
5.01 AUD
318% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

PYC Therapeutics Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for PYC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

PYC Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one PYC stock?

The intrinsic value of one PYC stock under the Base Case scenario is 0.56 AUD.

Is PYC stock undervalued or overvalued?

Compared to the current market price of 1.2 AUD, PYC Therapeutics Ltd is Overvalued by 54%.

Back to Top